The following link is to the Outsourcing-Pharma.com website. It provides access to an interview with Quintiles VP, Jim Featherstone.
Biopharma needs value focused commercial model, says Quintiles.
In the interview, Featherstone points out that the increased pressures on R&D, manufacturing and clinical trials in the pharma industry - actually represent opportunties for commercial outsourcng partners. The challenge is for these outsourcing entities to provide more value throughout the value-chain. Not just traditional products and services, but enhanced offerings like better communication/ education with patients, payers and regulators. Service providers can offer the in-house expertise and experience in these areas that their clients may lack in either experience or manpower.
It's a new model of a full-service supplier that is trying to provide more integrated end-to-end solutions throughout the process. I think many vendors are seeing that partnering opportunities -- and commercial success -- ultimately depend upon their ability to provide this level of integration with their customer base.
When opportunity knocks, someone needs to step up and answer the door.
Posted by Bruce Lehr September 22nd 2010.
Comments